Germany's nationwide PRAIM study found AI-assisted mammogram reading raised the breast-cancer detection rate by 17.6%, adding to a wave of 2026 studies from Sweden and South Korea supporting AI as a screening aid.
Abridge's ambient AI documentation tool, built with Epic and Mayo Clinic nurses, is now live at more than 250 U.S. health systems, extending AI scribing from physicians into nursing, ER, and post-acute care.
The EQUAL trial found Apple Watch-based AI heart monitoring detected atrial fibrillation in 9.6% of high-risk older adults versus 2.3% with standard care, bolstering the case for wearable-based stroke prevention.
Illinois's new WOPR Act bans AI chatbots from delivering psychotherapy or clinical decisions, with fines up to $10,000 per violation, making it the latest of four states to restrict AI mental-health tools in 2026.
Slingshot AI withdrew its Ash therapy chatbot from the UK in January 2026, citing unclear medical-device regulations, spotlighting the growing legal gray zone around AI mental-health apps.
DermaSensor's handheld AI device, cleared by the FDA for primary-care use, detects the three most common skin cancers with 96% sensitivity, aiming to catch melanoma earlier outside dermatology offices.
Aureka Biotechnologies raised $100 million to build a 'biological world model' that simulates antibody design rather than just predicting protein structure, entering a crowded AI drug discovery funding field dominated by billion-dollar players.
A Minnesota federal judge ordered UnitedHealth to disclose internal documents on its nH Predict algorithm, which plaintiffs allege has a 90% error rate in denying Medicare Advantage patients' post-acute care.
California's SB 243, now eight months into enforcement, requires AI companion chatbots to detect suicidal ideation and gives users the right to sue directly — a first-in-the-nation law shaping a growing patchwork of state AI mental health regulation.
University of Pennsylvania researchers built ApexGO, a generative AI system that redesigns weak antibiotic peptide candidates, and two of its AI-optimized molecules matched last-resort antibiotic polymyxin B in mouse infection tests, according to a study published in Nature Machine Intelligence.